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S U M M A R Y
Background: Previous studies have focused on the role of age as a prognostic factor in pyogenic liver
abscess (PLA) and results have been controversial. The aim of this study was to compare the clinical
characteristics of PLA in elderly (age 65 years) and non-elderly patients in order to identify any
differences so that an early diagnosis can be made and appropriate therapeutic measures can be
instituted promptly.
Methods: We performed a retrospective analysis of patients with PLA. The demographic and clinical
features, laboratory and imaging ﬁndings, management, and clinical outcomes of elderly and non-elderly
patients were studied.
Results: Between January 2000 and December 2010 inclusive, 319 patients had PLA; 168 (52.7%) were
aged 65 years. Elderly patients were more likely to have acute onset of symptoms (4.2 vs. 5.3 days,
p < 0.04), co-morbidities, and respiratory symptoms (25.6% vs. 14.6%, p < 0.01). They also had lower
serum bilirubin (28.1 vs. 37.1 mmol/l, p < 0.04), alanine aminotransferase (71.6 vs. 94.3 U/l, p < 0.02),
and glycosylated hemoglobin (8.1% vs. 10%, p < 0.01), and more often had septal lobulation (64.3% vs.
54.3%, p < 0.04) and pneumobilia (10.1% vs. 4.0%, p < 0.02). Moreover, they required a longer duration of
oral antibiotics (2.63 vs. 2.05 weeks, p < 0.01) and had a higher incidence of acute coronary syndrome
during the illness (7.7% vs. 2.0%, p < 0.01). Gram-negative organisms were the dominant isolates in both
groups, but the elderly had a lower incidence of Gram-positive infections (5.4% vs. 13.2%, p < 0.01).
Lastly, old age was associated with local recurrence of PLA (odds ratio (OR) 3.1, 95% conﬁdence interval
(CI) 1.0–9.7, p < 0.04) and mortality (OR 3.17, 95% CI 1.25–8.04, p = 0.015).
Conclusions: Elderly patients tend to have a more atypical presentation in PLA, for which clinicians
should be on high alert. We found older age to be associated with a higher recurrence of PLA and a higher
mortality rate.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Pyogenic liver abscess (PLA) has been recognized since the time
of Hippocrates. It is the most common type of visceral abscess; in a
report of 540 cases of intra-abdominal abscesses, PLA accounted
for 48% of visceral abscesses.1 In the past, this condition was
regarded as a potentially life-threatening condition, with a
mortality rate of up to 77%.2,3 Even with the advances in diagnostic
techniques and therapeutic modalities, the case-fatality rate
remains within the range of 10–40%.4–6 One possible reason is
the increased mean age of patients with PLA.7,8 Only a few studies
have speciﬁcally focused on the role of age in PLA in the past few
years,7,8 with controversial results, probably due either to the lack
of an appropriate comparison group or to the small sample size in
these studies.9–12 A recent retrospective study in Taiwan suggested* Corresponding author.
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patients.8 Despite having a large sample size, this study only
included patients with bacterial pathogens identiﬁed in the blood
and/or abscess culture. Another retrospective study from Taiwan
with a larger sample size, however, revealed that older patients
had a higher mortality in PLA and that this might be related to their
higher incidence of malignancy and septic shock.13 Furthermore, a
recent nationwide claimed-based retrospective study from Taiwan
also reported age as having a negative impact on the prognosis in
patients with PLA.14 Apart from the aforementioned studies from
Taiwan, there are no other studies regarding the inﬂuence of age on
PLA in Eastern Asia. Therefore further studies are warranted to
explore how the clinical features and management of elderly
patients with PLA differ from those of younger individuals.
Knowledge of such differences may heighten clinical suspicion,
given the atypical presentation of illness often seen in elderly
patients.
In Hong Kong, the geriatric population is growing continuously
and the role of advanced age in PLA could be a signiﬁcant issue. Ases. Published by Elsevier Ltd. All rights reserved.
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found that PLA in Hong Kong is clinically similar to that in
Taiwan.15We therefore designed this study to compare the clinical
features and management of PLA in elderly and non-elderly
patients in order to identify any differences so that an early
diagnosis can be made and appropriate therapeutic measures can
be instituted promptly.
2. Methods
This was a retrospective analysis in which the records of
patients discharged from Tuen Mun Hospital (TMH) in Hong Kong
with a diagnosis of pyogenic liver abscess (International Classiﬁ-
cation of Diseases code 572.0) between January 2000 and
December 2010 were reviewed. Cases were identiﬁed using the
Clinical Data Analysis and Reporting System (CDARS). According to
the 2009 census in Hong Kong, there were approximately
1 000 000 residents living in our district. Our hospital is situated
in the less afﬂuent part of the city, with a median household
income below the average in Hong Kong, and thus residents in our
region rely heavily on the subsidized health care service we
provide. CDARS is a patient database search engine; this was used
to identify patients seen at TMH during the designated period with
a diagnosis of PLA.
The case deﬁnition required patients to have one or more space-
occupying lesions on liver imaging (either ultrasound (US) or
computed tomography (CT)), together with either a positive blood/
pus culture or the complete resolution of radiological abnormali-
ties following antimicrobial therapy. Patients with amoebic liver
abscesses were excluded. Potential cases were identiﬁed using
CDARS, and their medical records were assessed for eligibility.
Patients who fulﬁlled the above inclusion criteria were divided into
two groups: patients 65 years of age constituted the elderly
group and those aged <65 years constituted the non-elderly group.
The clinical records of these patients were retrospectively
reviewed, with attention to the demographic characteristics,
clinical features, laboratory and imaging ﬁndings, treatment
methods, and ﬁnal outcomes.
2.1. Looking for the underlying etiology
The PLA was considered secondary to biliary tract disease in
patients with a clinical picture of cholecystitis or cholangitis, or a
documented biliary ductal abnormality.16–18 It was ascribed
secondary to portal spread when there was a documented
infection or abdominal pathology in the distribution of the portal
vein. It was considered secondary to hematogenous spread when a
documented bacteremic episode with another source of infection
was found. Cryptogenic abscess was deﬁned when there was no
obvious source of infection after appropriate investigations.
Recurrence was deﬁned as the re-development of the clinical
and radiological changes subsequent to clinical and/or radiological
resolution of the PLA.19 In-hospital mortality was deﬁned as death
resulting directly from the abscess or from a complication of
treatment.19
2.2. Management strategies
In general, intravenous broad-spectrum antibiotics were given
after the initial sepsis work-up. Imaging was carried out in every
case of suspected PLA, and percutaneous needle aspiration of the
liver abscess was undertaken if the abscess was >3 cm in diameter
or if there was a feature of ongoing sepsis despite antibiotic
treatment. The procedure was usually performed using a 22-gauge
Chiba needle under real-time US or CT guidance in the radiology
department. The decision for continuous catheter drainage wasmade by the attending radiologists, and the drainage was done
using an 8-French pigtail catheter. Surgical drainage was reserved
for patients who failed to respond to antibiotics and percutaneous
drainage, or for those who had a surgical indication requiring an
open surgical intervention. The purulent material in the abscess
cavity was sent for microbiological identiﬁcation and antimicro-
bial sensitivity testing. Antibiotic resistance was deﬁned as the
ability of a microbial isolate to survive and reproduce in the
presence of an antibiotic dosage that was thought to be effective
against it. The antibiotic therapy was then adjusted according to
the antimicrobial sensitivity of the isolate. The decision to switch
to an oral antibiotic counterpart was made by the attending
physicians. Lastly, follow-up imaging was performed to conﬁrm
the resolution of the liver abscess.
2.3. Statistical analysis
The data were compiled and analyzed using commercial SPSS
for Windows software (version 17.0; SPSS Inc., Chicago, IL, USA). All
continuous variables were expressed as the mean  standard
deviation (SD). Categorical variables were reported as percentages.
Univariate analysis was initially used to screen for potentially useful
variables associated with mortality, and in order to avoid the
premature exclusion of useful predictors due to a lack of statistical
power, those variables with p < 0.2 were selected for multivariate
logistic regression analysis to identify their independency associated
with mortality. Odds ratios (ORs) and their 95% conﬁdence intervals
(CIs) were estimated in the regression model. The Student’s t-test,
Chi-square test, Fisher’s exact test, and Mann–Whitney U-test were
used when appropriate. Two-sided p-values of <0.05 were considered
to be statistically signiﬁcant.
There were only 17 cases of local recurrence of PLA during the
study period and such a limited number precluded any regression
analysis, so Chi-square testing was used instead to explore
associations between factors of interest and local recurrence.
3. Results
3.1. Demographic characteristics
Three hundred sixty-seven patients were selected using CDARS
for the diagnosis of PLA between January 2000 and December 2010.
Forty-eight of these patients did not meet the eligibility criteria, of
whom 21 did not have any imaging before their death and their
diagnosis of PLA was provisional, 13 had a hepatic neoplasm
(hepatocellular carcinoma in eight and cholangiocarcinoma in ﬁve
patients) without any septic component inside, 12 patients were
given an incorrect diagnostic code, and the remaining two patients
had hepatic amoebic abscesses. Thus, during the designated
period, a total of 319 patients were diagnosed with PLA; of these,
168 (52.7%) were aged 65 years.
The crude annual incidence rate during the 11-year period was
2.9 per 100 000 population (range 0.9–5.3) and the corresponding
incidence rate in the elderly during the same period was 1.53 per
100 000 population (range 0.4–2.6) (Figure 1). The incidence rates
in both groups increased to a similar extent.
The demographic characteristics of these patients are shown in
Table 1. The male dominance was greater in the non-elderly group
(p < 0.03). The mean age at presentation was 77.3 years (range 65–
97 years; median 77.3 years) in the elderly group and 52.6 years
(range 24–64 years; median 55 years) in the non-elderly group.
Major co-morbidities in the two groups included diabetes mellitus,
hypertension (39.3% vs. 17.9%, p < 0.01), ischemic heart disease
(13.1% vs. 4.0%, p < 0.01), and stroke (16.1% vs. 4.0%, p < 0.01), with
statistically signiﬁcant differences between the elderly and non-
elderly groups for the latter three entities.
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Figure 1. The annual incidence rate of pyogenic liver abscess between 2000 and 2010.
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The clinical features of PLA in the elderly and non-elderly
patients are shown in Table 1. Elderly patients were more likely to
have an acute onset of presentation (4.2 vs. 5.3 days, p < 0.04) and
respiratory symptoms (25.6% vs. 14.6%, p < 0.01) than their non-
elderly counterparts, whereas non-elderly patients were more
likely to have diarrhea (10.6% vs. 3.6%, p < 0.01) and jaundice (9.9%
vs. 3.6%, p < 0.02).
3.3. Laboratory, radiological, and microbiological features
Laboratory ﬁndings are summarized in Table 2. The total
bilirubin (37.1 vs. 28.1 mmol/l, p < 0.04), alanine aminotransferase
(94.3 vs. 71.6 U/l, p < 0.02), and glycosylated hemoglobin (10% vs.
8.1%, p < 0.01) were higher in the non-elderly group, however
more elderly patients had bacteremia (46.4% vs. 37.1%, p < 0.03) on
admission. The characteristics of PLA found on radiological
imaging are shown in Table 2. Despite having a similar appearance
on US and CT imaging, septal lobulation (64.3% vs. 54.3%, p < 0.04)
and pneumobilia (10.1% vs. 4.0%, p < 0.02) were more commonly
seen in the elderly patients.
The microbiological etiologies in the two groups are summa-
rized in Table 3. The incidence of Gram-positive infection in the
elderly group was much lower than in the non-elderly group (5.4%
vs. 13.2%, p < 0.01). In the non-elderly group, the dominant Gram-
positive organism was Streptococcus milleri and the rest included
three cases of Staphylococcus aureus (including one patient withTable 1
Demographic and clinical characteristics of elderly and non-elderly patients with pyog
Variable Eld
(n =
Age, years, mean (SD) 77.
Sex, male/female 86/
Co-morbidities
Diabetes mellitus 49 
Hypertension 66 
Ischemic heart disease 22 
Stroke 27 
Active hepatic malignancya 24 
Duration of symptoms before presentation, days, mean (SD) 4.2
Symptoms and signs
Fever and chills 157
Right upper quadrant pain 90 
Diarrhea 6 (
Respiratory symptomsb 43 
Confusion 8 (
Jaundice 6 (
Hepatomegaly 9 (
Right pleural effusion/consolidation (on admission) 23 
Data are n (%) unless otherwise indicated. SD, standard deviation.
a Either primary or secondary metastases.
b Includes cough, sputum production, and/or dyspnea.underlying inﬂammatory bowel disease and the colonoscopy
revealed multiple colonic ulcerations; one patient with advanced
gastric cancer with hepatic metastases), one case of Clostridium
perfringens in a patient with advanced colonic cancer with hepatic
metastasis, and one case of Actinomyces in a patient with AIDS.
3.4. Pathogenesis
From the clinical data and radiological ﬁndings, a biliary tract
disorder was the most common cause of PLA in the two groups, in
which the dominance was much stronger in the elderly group
(78.0% vs. 45.7%, p < 0.01); this explained the fact that endoscopic
retrograde cholangiopancreatography (ERCP) was the most
commonly (38.6%) used therapeutic tool in this study. No causes
could be identiﬁed in 16 (5.0%) patients, with a statistically
signiﬁcant difference between the two groups. Lastly, more than a
ﬁfth of patients had not been investigated for the underlying cause.
3.5. Management
The management of the two groups is summarized in Table 4.
All patients received intravenous broad-spectrum antibiotics after
assessment for sepsis. Broad-spectrum penicillin (32.3%) and
third-generation (27.3%) and second-generation (26.6%) cepha-
losporins were the common intravenous antibiotics used. The most
commonly used oral antibiotics were broad-spectrum penicillin
(33.2%), quinolones (21.9%), and second-generation cephalospor-
ins (18.8%).enic liver abscess
erly group
 168)
Non-elderly group
(n = 151)
p-Value
3 (8) 52.6 (10.1)
82 95/56 <0.03
(29.2%) 41 (27.2%) 0.32
(39.3%) 27 (17.9%) <0.01
(13.1%) 6 (4.0%) <0.01
(16.1%) 6 (4.0%) <0.01
(14.3%) 16 (10.6%) 0.16
 (2.2) 5.3 (2.8) <0.04
 (93.5%) 146 (96.7%) 0.2
(53.6%) 83 (55.0%) 0.45
3.6%) 16 (10.6%) <0.01
(25.6%) 22 (14.6%) <0.01
4.8%) 3 (2.0%) 0.09
3.6%) 15 (9.9%) <0.02
5.4%) 8 (5.3%) 0.48
(13.7%) 19 (12.6%) 0.37
Table 2
Laboratory ﬁndings and radiological features of elderly and non-elderly patients with pyogenic liver abscess
Elderly group
(n = 168)
Non-elderly group
(n = 151)
p-Value
Laboratory parameters
Hemoglobin, g/dl, mean (SD) 11 (1.9) 11.3 (2.0) 0.13
White cell count, 109/l, mean (SD) 17.7 (2.6) 16.1 (1.8) 0.06
Erythrocyte sedimentation rate, mm/h, mean (SD) 76.6 (14.2) 81.2 (17.8) 0.42
C-reactive protein, mg/l, mean (SD) 137.3 (15) 142.4 (14.5) 0.81
Albumin, g/l, mean (SD) 28.3 (5.5) 30.5 (5.7) 0.01
Total bilirubin, mmol/l, mean (SD) 28.1 (1.7) 37.1 (4.0) <0.04
Alanine aminotransferase, U/l, mean (SD) 71.6 (5.0) 94.3 (7.5) <0.02
Hemoglobin A1c, %, mean (SD) 8.1 (1.8) 10 (3.1) <0.01
Bacteremia 78 (46.4%) 56 (37.1%) <0.03
Radiological featuresa
Size, cm, mean (SD) 6.3 (3.2) 6.0 (2.7) 0.07
Site
Right lobe 108 (64.3%) 100 (66.2%) 0.33
Left lobe 48 (28.6%) 35 (23.2%) 0.12
Bilobar 12 (7.1%) 16 (10.6%) 0.15
Echogenicity
Hypoechoic 112 (90.3%) 98 (90.7%) 0.31
Hyperechoic/heterogeneous 12 (9.7%) 10 (9.3%) 0.40
Thickened wallb 36 (21.4%) 32 (21.2%) 0.46
Rim enhancement 80 (47.6%) 83 (55.0%) 0.09
Septal lobulation 108 (64.3%) 82 (54.3%) <0.04
Pneumobilia 17 (10.1%) 6 (4.0%) <0.02
Fluid/gaseous cavitation 146/8 (86.9%/4.8%) 129/19 (85.4%/12.6%) 0.31/<0.01
Portal thrombophlebitis 3 (1.8%) 6 (4.0%) 0.13
Subcapsular rupture of the abscess 13 (7.7%) 6 (4.0%) 0.08
Data are n (%) of patients, unless otherwise indicated.
a Ultrasound in 124 of the elderly group and 108 of the non-elderly group; computed tomography scan performed in all patients.
b Reference 40.
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which 38 (64.4%) were from the elderly group; probable reasons
in this group were: antibiotic exposure prior to admission (10;
26.3%), a history of recurrent pyogenic cholangitis (RPC) (8;
21.1%), mixed growth (14; 36.8%), and unknown (6; 15.8%). Most
of the resistant strains bore isolated penicillin resistance. Only
one isolate from each group was an extended-spectrum beta-
lactamase (ESBL) strain of bacterium. Despite antibiotic resis-
tance, there was still an appropriate antibiotic available for use in
these cases.
The elderly group received a longer duration of oral antibiotics
as compared to the non-elderly group (2.63 vs. 2.05 weeks,
p < 0.01). Antibiotic therapy was the only treatment for 23 elderly
patients and 15 non-elderly patients, and the reason for not
performing image-guided aspiration and drainage was the small
size of the lesion (<3 cm in diameter). A pigtail catheter was not
inserted in 35 patients after percutaneous aspiration because the
abscess was too solid or it completely collapsed after aspiration
and thus further catheter drainage was considered not useful. The
indication for laparotomy among the patients of both groups was
the presentation of acute abdomen.
3.6. Clinical outcomes
Patients in the elderly group had a similar incidence of
complications to patients in the non-elderly group, except for
acute coronary syndrome (7.7% vs. 2.0%, p < 0.01).
The follow-up period for patients in this study was a mean of
40.0 months (range 2.75–125 months). Recurrence of PLA was
found in 17 (5.3%) patients in this study, and the median time to
local recurrence was 20 weeks (range 2–352 weeks). The OR of
local recurrence between the elderly and non-elderly groups was
3.1 (95% CI 1.0–9.7). It was strongly associated with old age
(p < 0.04), underlying biliary tract pathology (p = 0.04), and
particularly a history of RPC (p = 0.00) (Table 5).There were 51 (16.0%) deaths in this study and the median time
to death was 5 weeks (range 0.29–76 weeks), with a statistically
signiﬁcant difference between the two groups (log rank test,
p < 0.03). The OR of mortality between the elderly and non-elderly
groups was 3.17 (95% CI 1.25–8.04). By using multivariate logistic
regression analysis, old age (p = 0.015), underlying active malig-
nancy (p = 0.00), hypoalbuminemia (p = 0.01), and disseminated
intravascular coagulation (DIC) (p = 0.015) were independent risk
factors associated with mortality for the patients in the two groups
(Table 6). These risk factors, as a whole, contributed 60%
(Nagelkerke R2 = 0.60) of the mortality risk in our series.
4. Discussion
The current study is the ﬁrst investigation regarding the
inﬂuence of age on PLA in Eastern Asia apart from Taiwan, and
shows the role of age in PLA to be prominent. Although the current
study was not population-based, our local residents rely heavily on
our health care service and thus our data could reﬂect the
incidence rate in our population to a certain extent. The increasing
global incidence rate of PLA is supported by our data. Our reported
incidence rate of PLA is similar to that in Caucasian populations
(3.6/100 000 in the USA and 2.3/100 000 in Canada), but is much
lower than that of the population of Taiwan (17.6/100 000).20–22
The reason behind the exceptionally high incidence rate of PLA in
the population of Taiwan might be related to the strong association
of PLA with diabetes mellitus (according to data from Taiwan, the
prevalence rate of diabetes mellitus was 47.57% in patients with
liver abscess).23,24
The mean age of the whole patient population in our series is
comparable to that of previous series.13,14,19,25 The trend in
gender distribution with age reﬂects the longer life-expectancy
of females than males. It is not surprising that co-morbidities
such as hypertension, ischemic heart disease, and stroke were
found more in older patients. The duration of symptoms prior to
Table 3
The bacteriology, pathogenesis, and conﬁrmatory investigations in elderly and non-elderly patients with pyogenic liver abscess
Elderly group
(n = 168)
Non-elderly group
(n = 151)
p-Value
Bacteriology
Gram-positive organism 9 (5.4%) 20 (13.2%) <0.01
Streptococcus milleri 6 (3.6%) 15 (9.9%)
Othera 3 (1.8%) 5 (3.3%)
Gram-negative organism 100 (59.5%) 79 (52.3%) 0.1
Escherichia coli 23 (13.7%) 6 (4.0%)
Klebsiella spp 71 (42.3%) 69 (45.7%)
Otherb 6 (3.6%) 4 (2.6%)
Mixed growth 36 (21.4%) 27 (17.9%) 0.22
Unknown 23 (13.7%) 25 (16.6%) 0.24
Antibiotic resistance 38 (22.6%) 21 (13.9%) <0.03
Type of resistance
Penicillin 34 20
ESBL 1 1
Quinolone 3 0
Pathogenesis
Biliary tract disorder 131 (78.0%) 69 (45.7%) <0.01
Portal pyemiac 5 (3.0%) 9 (6.0%) 0.10
Hematogenousd 2 (1.2%) 4 (2.6%) 0.06
Cryptogenic 5 (3.0%) 11 (7.3%) 0.02
Not investigated 25 (14.9%) 58 (38.4%) <0.01
Conﬁrmatory investigations
Endoscopic retrograde cholangiopancreatography 72 51
Biliary tree calculi 19 (26.4%) 12 (23.5%)
Dilated biliary tree without any calculi 9 (12.5%) 3 (5.9%)
Recurrent pyogenic cholangitis 13 (18.1%) 6 (11.8%)
Normal biliary tree 26 (36.1%) 29 (56.9%)
Othere 5 (6.9%) 1 (1.9%)
Endoscopic ultrasoundf 3 5
Magnetic resonance cholangiopancreatographyg 2 9
Colonoscopyh 6 7
ESBL, extended-spectrum beta-lactamase.
a Elderly: Enterococcus (3). Non-elderly: Staphylococcus aureus (3), Clostridium perfringens (1), Actinomyces (1).
b Elderly: Enterobacter (4), Citrobacter (1), Bacteroides (1; patient with underlying recurrent pyogenic cholangitis complicated with cholangiocarcinoma). Non-elderly:
Proteus (1), Citrobacter (1; patient with underlying recurrent pyogenic cholangitis complicated with cholangiocarcinoma), Fusobacterium (2).
c Elderly: colonic diverticulitis (3), acute appendicitis (1), advanced colonic cancer (1). Non-elderly: colonic diverticulitis (5), inﬂammatory bowel disease (2), acute
appendicitis (1), advanced colonic cancer (1).
d Elderly: urinary tract infection (2). Non-elderly: pneumonia (1), right psoas abscess (1), gastric cancer (1), continuous ambulatory peritoneal dialysis (1).
e Elderly: cholangiocarcinoma (2), failure of cannulation (2), benign stricture (1). Non-elderly: benign stricture (1).
f Elderly: cholangiocarcinoma (1), pancreatic cyst (1), normal (1). Non-elderly: liver cyst (1), normal (4).
g Elderly: biliary tract calculi (1), cholangiocarcinoma (1). Non-elderly: normal (7), recurrent pyogenic cholangitis (1), biliary tract calculi (1).
h Elderly: normal (4), colonic diverticulitis (1), colonic cancer (1). Non-elderly: normal (4), colonic diverticulitis (2), inﬂammatory bowel disease (1).
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the non-elderly group, which is consistent with the observation
of Chen et al.8 This could be explained by the fact that PLA will
present most acutely (3 days) if it is due to a biliary tract
disorder.26 Moreover, elderly patients might be taken to hospital
earlier because their families are concerned about their
constitutional symptoms and the difference might reﬂect this
earlier presentation.
Although the clinical manifestations of PLA were similar in the
two groups, the elderly patients were more likely to experience
respiratory symptoms, which might be due to the cardiopulmo-
nary distress triggered by the septic process. The non-elderly
patients were more likely to have diarrhea and jaundice, which are
related to their higher incidence of portal pyemia and longer
duration of symptoms, respectively. Thus, physicians need to be
alert to the diagnosis of PLA in the geriatric population.7,8
Laboratory abnormalities were similar in the two groups,
mainly anemia, leukocytosis, high erythrocyte sedimentation rate
and C-reactive protein, and deranged liver function tests with
elevated serum bilirubin and alkaline phosphatase. The change in
serum alanine aminotransferase, hyperbilirubinemia, and poor
diabetic control were less pronounced in elderly patients, which
may be due to the early presentation of the disease; however their
higher incidence of bacteremia on admission was reﬂected by
their own poor pre-morbid status. Right hepatic lobe involvementwas dominant in both patient groups, which is consistent with
prior reports.27–29 The imaging appearance of PLA in the two
groups was similar, except elderly patients were more likely to
have pneumobilia and septal lobulation. This observation might
be related to the higher incidence of biliary tract disease in the
elderly group. The bacterial pathogens spread along the biliary
tree to form cholangitic abscesses at their proximal ends and
subsequently coalesce to form a larger abscess with septal
lobulation. The pneumobilia could be explained by the reﬂux of
enteric gas into the biliary tree after the passage of calculi through
the ampulla of Vater.
The pattern of bacteriology was different in the two groups. The
elderly patients had a lower incidence of Gram-positive organisms
identiﬁed and this might be related to their lower incidence of
portal pyemia. Another major difference was that the combination
of positive cultures of Klebsiella spp and Escherichia coli from pus/
blood specimens was more commonly found in the older than in
the younger participants. This ﬁnding is different from those of
previous reports on older patients in Western countries, but is
consistent with the ﬁndings in studies conducted in Asia.7,14,30–32
Though Gram-positive organisms, notably Streptococcus milleri,
were found more frequently in the non-elderly patients, only two
patients were found to have inﬂammatory bowel disease as the
underlying cause of PLA, which is in contrast to the ﬁndings of the
study of Chua et al. in which Streptococcus milleri-associated PLA
Table 4
Management and outcomes of elderly and non-elderly patients with pyogenic liver abscess
Elderly group
(n = 168)
Non-elderly group
(n = 151)
p-Value
Antibiotic
Intravenous, weeks, mean (SD) 2.87 (1.69) 2.86 (1.72) 0.90
Broad-spectrum penicillin 55 (32.7%) 48 (31.8%) 0.38
Second-generation cephalosporin 41 (24.4%) 44 (29.1%) 0.17
Third-generation cephalosporin 47 (28.0%) 40 (26.5%) 0.38
Carbapenem 16 (9.5%) 14 (9.3%) 0.48
Quinolone 9 (5.4%) 5 (3.3%) 0.18
Oral, weeks, mean (SD) 2.63 (1.8) 2.05 (1.7) <0.01
Broad-spectrum penicillin 54 (32.1%) 52 (34.4%) 0.33
Second-generation cephalosporin 32 (19.0%) 28 (18.5%) 0.46
Quinolone 36 (21.4%) 34 (22.5%) 0.07
Other 46 (27.4%) 37 (24.5%) 0.35
Intervention
Imaging-guided aspiration  drainage 134/117 (79.8%/69.6%) 128/110 (84.8%/72.8%) 0.10/0.26
Surgical drainage 11 (6.5%) 8 (5.3%) 0.39
Complications and outcomes
Metastatic infectiona 8 (4.8%) 8 (5.3%) 0.32
Septic shock 48 (28.6%) 43 (28.5%) 0.50
DIC 25 (14.9%) 25 (16.6%) 0.34
Acute coronary syndrome 13 (7.7%) 3 (2.0%) <0.01
Respiratory/renal failure 7 (4.2%) 4 (2.6%) 0.21
ICU care 16 (9.5%) 16 (10.6%) 0.37
Recurrence 13 (7.7%) 4 (2.6%) 0.02
Death 37 (22.0%) 14 (9.3%) <0.01
Liver abscess 12 2
Active hepatic malignancyb 18 11
Otherc 7 1
Data are n (%) of patients, unless otherwise indicated. SD, standard deviation; DIC, disseminated intravascular coagulation; ICU, intensive care unit.
a Elderly: urinary tract infection (5), right empyema (1), endophthalmitis (1), urinary tract infection plus endophthalmitis (1). Non-elderly: urinary tract infection (3),
pneumonia (2), endophthalmitis (2), right psoas abscess (1).
b Either primary or secondary metastases.
c Elderly: hospital-acquired pneumonia (3), stroke (2), uncontrolled duodenal ulcer bleeding (2). Non-elderly: hospital-acquired pneumonia (1).
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because inﬂammatory bowel disease is still not as common in
Asian populations as in Caucasians.33,34 Although colonoscopy,
ERCP, and endoscopic US were performed with poor coverage, a
biliary disease was still the most common identiﬁable cause of PLA
in both groups of patients, as has been noted in other recent
reports.14,15,26,35
Our study shows that there were no signiﬁcant differences in
the therapeutic procedures performed or antibiotics adminis-
tered between the two groups; however the duration of oral
antibiotics offered was longer in the elderly group than in the
non-elderly group, which was probably related to the host
condition rather than the treatment of PLA per se. Consistent
with previous reports, antibiotic resistance was found in a ﬁfth
of the overall isolates in this study, with a statisticallyTable 5
Summary of the analysis of clinical factors in recurrence in all patients with
pyogenic liver abscessa
Variable Recurrence
(n = 17)
No recurrence
(n = 302)
p-Value
Age 65 years 13 (76.5%) 155 (51.3%) <0.04
Biliary tract pathology 16 (94.1%) 184 (60.9%) 0.04
History of recurrent
pyogenic cholangitis
10 (58.8%) 17 (5.6%) 0.00
Active hepatic malignancyb 3 (17.6%) 37 (12.3%) 0.71
Bacteremia 5 (29.4%) 129 (42.7%) 0.32
Metastatic infection 0 (0%) 16 (5.3%) 0.61
Antibiotic resistance 3 (17.6%) 56 (18.5%) 0.99
Data are n (%) of patients.
a Performed by Chi-square test as there were only 17 cases with local recurrence.
b Either primary or secondary hepatic metastases.signiﬁcant difference between the two groups.8 This difference
can be explained by the fact that more elderly patients had a
history of antibiotic exposure prior to admission (12 (31.6%) vs.
2 (9.5%), p < 0.03; data not shown). Due to the liberal use of
antibiotics in clinical practice nowadays, the incidence of
antimicrobial resistance is expected to increase and this may
have clinical implications in the future.
Consistent with the ﬁndings of a previous report, the higher
recurrence rate of PLA in elderly patients observed in our study was
related to the underlying persistent morphological abnormalities
of the biliary tree, particularly RPC.36 Because of the small number
of local recurrences in our series, multivariate logistic analysis
could not be performed for the prediction of local recurrence
because of the possibility of over-ﬁtting of the model. In this study,
the overall mortality rate of PLA was 16%, which is comparable to
the rates found in other studies.19,25,27–29,37 There was a
statistically signiﬁcant difference in mortality rate between the
two groups. In the present study, we were able to show that older
age, underlying active malignancy, hypoalbuminemia, and DIC
were independent risk factors for in-hospital mortality after
adjustment for confounding variables. The impact of advanced age
on the survival of patients with PLA supports the ﬁndings of
previously published studies.13,19 The prognostic value of under-
lying active hepatic malignancy has been recognized in other
reports.13,15,38–41 Hypoalbuminemia might reﬂect the duration of
growth of the liver abscess and impairment of hepatic synthetic
function. DIC may relate to the severity of the septic process. There
are several potential risk factors that have been shown to be
signiﬁcant in other studies but did not have any prognostic value in
the current study.19,35,37,42–44 The issue of discrepancy with regard
to the prognostic factors of PLA may be due to differences in subject
populations.
Table 6
Summary of the analysis of clinical factors in mortality in all patients with pyogenic liver abscess
Variable Wald estimatea Beta coefﬁcient (B) Odds ratiob (95% CI) Signiﬁcancec
Univariate p-value Multivariate p-value
Co-morbidity
Diabetes mellitus 0.536 -
Ischemic heart disease 0.253 -
Stroke 0.441 -
Bacteremia 0.660 -
Metastatic infection 0.268 -
Age 65 years 5.90 1.15 3.17 (1.25–8.04) 0.030 0.015
Active hepatic malignancyd 59.73 4.21 67.20 (23.12–195.33) 0.000 0.000
Serum albumin <28 g/dl 6.70 1.23 3.42 (1.35–8.69) 0.050 0.010
Serum bilirubin >30 mmol/l 0.96 0.43 1.54 (0.65–3.68) 0.09 0.327
DIC 5.88 1.41 4.10 (1.31–12.82) 0.017 0.015
Acute coronary syndrome 3.59 1.47 4.35 (0.95–19.34) 0.043 0.058
Renal impairmente 0.02 0.1 1.11 (0.28–4.33) 0.072 0.886
Septic shock 0.01 0.04 1.04 (0.36–2.98) 0.027 0.938
ICU care 0.37 0.42 1.52 (0.39–5.87) 0.016 0.542
CI, conﬁdence interval; DIC, disseminated intravascular coagulation; ICU, intensive care unit.
a Wald estimate corresponds to the importance of the variable in the model.
b Odds ratio calculated by Exp(B).
c Performed by univariate regression and by multivariate logistic regression analysis.
d Either primary or secondary hepatic metastases.
e Serum creatinine 200 mmol/l.
S.-T. Law, K.K. Li / International Journal of Infectious Diseases 17 (2013) e177–e184 e183PLA in elderly patients tends to present as a distinct clinical
syndrome with regard to the pattern of clinical manifestations and
radiological and microbiological features. We found elderly
patients to be more prone to local recurrence and older age to
be associated with a higher mortality.
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